PT  - JOURNAL ARTICLE
AU  - Hassan, Mahmoud Adel
AU  - Ramadan, Ahmed
AU  - Tahoun, Mohamed Mostafa
AU  - Omran, Abdel Rahman
AU  - Ebrahim Ali, Shaimaa Gad EL Karim
AU  - Khedr Esmail, Ola Fahmy
AU  - Adel Elrewany, Ehab Mohamed
AU  - Ahmed El-Meligy, Passent Ehab El-din
AU  - Elzayat, Amira Mahmoud
AU  - el Malawany, Dina Hussein
AU  - Mahboob, Amira Saad
AU  - Eldewiki, Mohamed Kamal
AU  - Abdellatif Hammouda, Esraa Abdellatif Mohamed
AU  - Ghazy, Ramy Mohamed
TI  - Geospatial characterizing of Under-Five Mortality in Alexandria, Egypt
AID  - 10.1101/2021.04.24.21255886
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.04.24.21255886
4099  - http://medrxiv.org/content/early/2021/04/26/2021.04.24.21255886.short
4100  - http://medrxiv.org/content/early/2021/04/26/2021.04.24.21255886.full
AB  - This study aimed to identify geo-spatial pattern of under-five mortality (U5M) in Alexandria and its key determinants. We analyzed the geospatial distribution of 3064 deaths registered at 24 health offices reported from January 2018 to June 2019. The localities of Alexandria city were clustered into high and low incidence areas. Neonates represented 58.7% of U5M, while post-neonates and children were 31.1%, 10.2% respectively. Male deaths were significantly higher (P=0.036). The main leading causes of U5M were prematurity (28.32%), pneumonia (11.01%), cardiac arrest (10.57%), congenital malformation (9.95%), and childhood cardiovascular diseases (9.20%). Spatial distribution of U5M (including the most common three causes) tend to be clustered in western parts of Alexandria (El Hawaria, Bahig, Hamlis and Ketaa Maryiut). Another 9 clusters are at risk of being hotspots. Illiteracy, divorce, and poor locality characteristics (household size, population density, and access to water supply and sanitation), were statistically significant predictors of U5M.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo fund was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical clearance was sought and approved from the Ethics Committee of High Institute of Public Health, Alexandria UniversityAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData available upon request